Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers
Loncastuximab治疗高危且既往接受过大量治疗的复发/难治性弥漫性大B细胞淋巴瘤:来自美国21个中心的真实世界分析
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.285977
Zelikson, Viktoriya; Gurumurthi, Ashwath; Sawalha, Yazeed; Annunzio, Kaitlin; Saha, Aditi; Dong, Ning; Qualls, David; Amoozgar, Behzad; Kahl, Brad; Baird, John; Challa, Pavan; Huntington, Scott F; Santos, Jennifer; Bair, Steven; Narkhede, Mayur; Li, Shuning; Frosch, Zachary; Ho, Carrie; Smith, Stephen D; Winter, Allison; Landsburg, Daniel; Furqan, Fateeha; Hamadani, Mehdi; Baird, Katelin; Romancik, Jason; Alharthy, Hanan; Law, Jennie; Bojanini, Leyla; Advani, Ranjana; Hu, Boyu; Johnson, Patrick Connor; Grover, Natalie S; Merril, Mwanasha; Crombie, Jennifer L; Shafagati, Nazila; Sterling, Cole; Nastoupil, Loretta J; Epperla, Narendranath; Ayers, Emily C